Allshine Chen

Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges

The current state and future directions of RNAi-based therapeutics

Exosomes: biogenesis, biologic function and clinical potential

Tumour acidosis: from the passenger to the driver's seat

Pyroptosis: A new frontier in cancer

Extracellular vesicles in cancer — implications for future improvements in cancer care

Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors

RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment

Reactive Oxygen Species (ROS)-Based Nanomedicine

Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device

Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration